Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06979557 · ClinicalTrials.gov registry record
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
A clinical trial of Refractive Lens Exchange, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06979557: Completed study of Refractive Lens Exchange, sponsored by Mann Eye Institute.
NCT06979557 is a study of Refractive Lens Exchange that has completed, run by Mann Eye Institute. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06979557, a study of Refractive Lens Exchange, has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.
Primary Outcome
Measured at distance (6m), intermediate at 66cm, and near visual acuity at 40cm and 33cm.
Conditions Studied
Interventions
- DEVICE Odyssey IOL
Study Locations (1)
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-21 |
| Est. Completion | 2026-01-01 |
What the finished NCT06979557 record still lists
NCT06979557 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Refractive Lens Exchange appearing as the primary indexed condition, and to 1 intervention - of which Odyssey IOL is the first listed.
NCT06979557 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06979557 about?
NCT06979557 is a clinical study titled "RLE Outcomes With Bilateral Implantation of Odyssey IOLs". This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as mea...
What is the current status of trial NCT06979557?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2025-07-21. Estimated completion is 2026-01-01.
What conditions does trial NCT06979557 study?
This clinical trial studies the following conditions: Refractive Lens Exchange.
What interventions are being tested in trial NCT06979557?
The interventions under investigation include: Odyssey IOL (DEVICE).
Who is sponsoring clinical trial NCT06979557?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06979557 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI